vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
31.97
+2.57 (8.74%)
Apr 28, 2026, 4:00 PM EDT - Market closed
vTv Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 397 | 496 | 91 | 23 | 54 | 67 | |
| Market Cap Growth | 251.41% | 445.89% | 288.02% | -56.62% | -18.92% | -32.00% | |
| Enterprise Value | 308 | 398 | 52 | 27 | 64 | 93 | |
| Last Close Price | 31.97 | 39.99 | 13.81 | 11.50 | 26.51 | 39.80 | |
| PS Ratio | - | - | 89.38 | - | 26.76 | 16.63 | |
| PB Ratio | 6.16 | 7.70 | 6.36 | -1.26 | 9.25 | 4.38 | |
| P/TBV Ratio | 6.16 | 7.70 | 7.45 | - | - | - | |
| EV/Sales Ratio | - | - | 51.49 | - | 31.69 | 23.20 | |
| Debt / Equity Ratio | - | - | 0.01 | -0.03 | 0.12 | 0.06 | |
| Net Debt / Equity Ratio | -1.38 | -1.38 | -2.56 | 0.48 | -1.96 | -0.83 | |
| Net Debt / EBITDA Ratio | 2.71 | 2.71 | 1.52 | 0.35 | 0.51 | 0.63 | |
| Net Debt / FCF Ratio | 3.52 | 3.52 | 1.45 | 0.47 | 0.71 | 0.65 | |
| Asset Turnover | - | - | 0.04 | - | 0.07 | 0.20 | |
| Quick Ratio | 13.39 | 13.39 | 7.07 | 0.91 | 1.60 | 1.61 | |
| Current Ratio | 13.54 | 13.54 | 7.34 | 1.00 | 3.52 | 1.84 | |
| Return on Equity (ROE) | -78.94% | -78.94% | - | - | -238.10% | -186.50% | |
| Return on Assets (ROA) | -32.00% | -32.00% | -61.33% | -72.03% | -47.99% | -62.28% | |
| Return on Capital Employed (ROCE) | -39.40% | -39.40% | -73.10% | -6391.50% | -88.30% | -118.20% | |
| Earnings Yield | -6.80% | -5.44% | -20.31% | -86.44% | -35.48% | -19.50% | |
| FCF Yield | -6.37% | -5.09% | -27.84% | -81.45% | -29.70% | -28.99% | |
| Buyback Yield / Dilution | -45.96% | -45.96% | -176.79% | -8.60% | -22.58% | -32.90% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.